Ovarian Cancer Trial, Recruiting (NCT07213193)

Ovarian Cancer Trial, Recruiting NCT07213193 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07213193 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a suspected or confirmed diagnosis of a malignant (cancerous) ovarian tumour and are scheduled for planned surgery to remove as much of the tumour as possible, which will involve removing part of the large bowel (the rectum and sigmoid colon) and rejoining the ends.
You have signed a consent form agreeing to take part before any trial-related procedures begin.
You are 18 years of age or older.

Who may not be able to join:

Your cancer is not an ovarian tumour (for example, if it originates from a different organ or tissue type).
Your surgery is planned for comfort or symptom relief only, rather than to remove the cancer.
During the operation, the surgical team decides that removing part of the large bowel is not actually needed after all.
During the operation, instead of rejoining the bowel ends, you require a stoma (an opening on the abdomen where waste is collected in a bag) rather than a reconnection.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Virginia Vargiu, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +393387106039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07213193

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

Trial contact: +393387106039

More information: https://clinicaltrials.gov/study/NCT07213193

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a suspected or confirmed diagnosis of a malignant (cancerous) ovarian tumour and are scheduled for planned surgery to remove as much of the tumour as possible, which will involve removing part of the large bowel (the rectum and sigmoid colon) and rejoining the ends.
You have signed a consent form agreeing to take part before any trial-related procedures begin.
You are 18 years of age or older.

Who may not be able to join:

Your cancer is not an ovarian tumour (for example, if it originates from a different organ or tissue type).
Your surgery is planned for comfort or symptom relief only, rather than to remove the cancer.
During the operation, the surgical team decides that removing part of the large bowel is not actually needed after all.
During the operation, instead of rejoining the bowel ends, you require a stoma (an opening on the abdomen where waste is collected in a bag) rather than a reconnection.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registry

ClinicalTrials.gov

Start date

1 May 2025

Est. completion

1 June 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Rate of Anastomotic Dehiscence in Low-Risk Patients Undergoing Primary or Secondary Cytoreductive Surgery for Ovarian, Fallopian Tube, or Peritoneal Tumors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov